Kontrol Technologies Corp N.KNR

Kontrol Q1 Results

[wilander]

Q1 as expected. I'm now Looking forward to the many catalysts in the works to start taking shape in Q2 and Q3. These next quarters will go a long way to defining/clarifying the success story we should have here. HC results from testing/evaluating Biocloud released in July can light the fuse if UAE distribution hasnt already by then. Its surely been a slower haul than anticipated but eye on the prize! PR NEWSWIRE Kontrol Technologies Announces Q1 2021 Financial Results 05/31/2021 4:33:00 PM TORONTO, May 31, 2021 /PRNewswire/ - Kontrol Technologies Corp. (NEO: KNR) (OTCQB: KNRLF) (FSE: 1K8) ("Kontrol Technologies" or "Kontrol" or the "Company") a leader in smart buildings and cities through IoT, Cloud and SaaS technology announces the release of its financial results for the three months ended March 31, 2021. A complete set of the Financial Statements and Management's Discussion & Analysis have been filed on SEDAR (www.sedar.com). Highlights Adjusted EBITDA* of $1.1 million in Q1 2021, up from $241,343 over the same quarter in the prior year Revenues of $3.3 million, up 20% over the same quarter in the prior year Cash flows from operating activities were $592,153 for the three months ended March 31, 2021; an improvement of $610,964 over the same quarter in the prior year The Company has invested approximately $4 million up to the end of Q1 in the development of BioCloud Conversions of convertible debentures to common shares totalled $631,000 during the first quarter of 2021 Proceeds from options and warrants exercise were $710,607 during the first quarter of 2021 Subsequent to Q1 2021, the Company announced on May 27, 2021, an $8.5 million private placement with institutional investors; closing date expected to occur on or about June 1, 2021 Capital management initiatives during the 2020 fiscal year and into 2021 have strengthened the balance sheet Manufactured hundreds of BioCloud units and closely managing the supply chain with manufacturing partners Project Seasonality and the Impact of Covid-19 on Operations Q1 is typically the quarter most impacted by seasonality and timing of projects. In Q1 approximately $500,000 in projects were impacted due to timing issues dealing with on-site restrictions during lockdown periods in Ontario. These projects will be delivered in Q3 and Q4. The Company has been affected by ongoing global supply chain issues related to computer processors and other components that are required for BioCloud manufacturing. The impact has been primarily due to long lead times and scarcity of components. The Company is actively working with its supply chain partners to manage the supply chain. There is no change to the Company's revenue and adjusted EBITDA targets previously presented on April 7, 2021.

[pointer]

This post has been removed in accordance with Community Policy

[canyousayiii]

The Q1 presser also said they "manufactured hundreds" of BioCloud units. What does that mean, at least 201? And nor reading more than it says, it sounds like these hundreds of units are sitting in their or their partners' warehouse facility and not sold because they did not reflect in revenues. If so much blame is being put on the supply chain, and these are finished units, should

[jawstoyz]

I cannot wait until the end of the next two quarters and listening to the cr.p coming out of your mouth.  Hey guys, this is what I expected and we have a bright future ahead.  I cannot wait until the next quarter, big things ahead lol.  Pointer was correct about you all along.  You're completely useless on this board.  If these financials get your approval, nobody